RAD BioMed

Incubator Active Tel Aviv-Yafo, Israel Est. 2011
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
15
in our dataset
Rounds participated
17
Rounds led
0
Rounds' value
$48.9M
total disclosed, rounds participated
Stages
A Round, Seed

About

RAD Biomed is an Israel-based private incubator that invests in early-stage biomedical and Hi-Tech start-ups. RAD Biomed invests in exciting new solutions at the earliest stages, providing a full set of operational and professional services, mentorship and industry connections. Rad Biomed was launched by the RAD Group, a group of independent companies that develop, manufacture, and market solutions for diverse segments of the networking and telecommunications industry. The RAD Group has decades of experience in guiding and nurturing start-ups as they grow towards commercial launch, sales growth, and successful exit, with nine Nasdaq IPOs and 10 M&As.

Portfolio · 15

FEMSelect
Treatment for Pelvic Floor Ligament Fixation
2 rounds $9.0M committed Latest: 2022-10
CVAid Medical
AI-based Stroke Disease Management Platform
1 round $4.0M committed Latest: 2022-02
Z-square
Microendoscope for Minimally Invasive Imaging and Treatment
1 round $10.0M committed Latest: 2019-02
Perflow Medical
Medical Device to Control Neurovascular Disorders
1 round $12.0M committed Latest: 2018-02
SynVaccine
Design and Construction of Viral-based Products
1 round $1.7M committed Latest: 2017-11
Everads Therapy
Delivery System for Injectable Therapies into the Eye
1 round $1.0M committed Latest: 2017-01
BELKIN Vision
One-second Laser Treatment for Glaucoma
2 rounds $1.1M committed Latest: 2015-07
Vectorious Medical Technologies
Miniature Implant for Left Atrial Monitoring
1 round $5.0M committed Latest: 2015-02
Laminate Medical Technologies
Implanted Device for Renal Vascular Procedures in Dialysis Patients
1 round $4.0M committed Latest: 2014-04
Radiaction
Radiation Shielding Device
1 round $1.0M committed Latest: 2014-01
Eon Surgical
Scarless Surgery Solutions
1 round Latest: 2010-05
Moebius Medical
Pain Relief for Osteoarthritis
1 round Latest: 2008-08
Situgen Med
Cord Blood Collection Device
1 round Latest: 2006-01
Simbionix
Training and Education Simulators for Medical Professionals
1 round Latest: 2001-06
Stepwise
Compact Laparoscopic Stapler
1 round

Investment activity

5 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences15
Education & Knowledge Technologies1

Q&A

What is RAD BioMed's primary investment focus?
RAD BioMed is an Israel-based private incubator that invests in early-stage biomedical and Hi-Tech start-ups. Their portfolio shows a strong concentration in Health Tech & Life Sciences.
Can you name some of RAD BioMed's recent notable exits?
RAD BioMed has had two significant exits recently. In July 2024, BELKIN Vision was acquired by Alcon Pharmaceuticals for $81M. Additionally, in September 2025, Vectorious Medical Technologies was acquired by Edwards Lifesciences for $497M.
What stages of investment does RAD BioMed typically engage in?
RAD BioMed primarily invests in Seed and A Round stages. According to startupim data, they have made 9 Seed investments and 3 A Round investments.
Who are the co-founders of RAD BioMed?
RAD BioMed was co-founded by Yehuda Zisapel and Nava Zisapel. Nava Zisapel also serves as the Chairperson.
Which portfolio companies have received B Round funding with RAD BioMed's involvement?
FEMSelect, a company focused on treatment for pelvic floor ligament fixation, has received B Round funding, raising $16.89M.
What is the most recent investment round RAD BioMed participated in?
The most recent investment round RAD BioMed participated in was in October 2022.
What kind of support does RAD BioMed provide to its portfolio companies?
RAD BioMed provides a full set of operational and professional services, mentorship, and industry connections to its early-stage portfolio companies.
Can you name a portfolio company of RAD BioMed that focuses on neurovascular disorders?
Perflow Medical is a portfolio company of RAD BioMed that develops medical devices to control neurovascular disorders. They have raised $13.6M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)